Important step forward for Phathom Pharmaceuticals as FDA accepts NDA for new daily heartburn drug 11-Dec-2023 By Liza Laws Millions of US adults suffering from heartburn associated with non-erosive-gastroesophageal-reflux-disease (GERD) could benefit from an impending treatment by Phathom Pharmaceuticals.